Celcuity (NASDAQ:CELC) announced its quarterly earnings results on Thursday. The company reported ($0.16) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.02, Fidelity Earnings reports.
Celcuity stock traded up $0.26 during trading hours on Friday, reaching $14.30. The company had a trading volume of 4,400 shares, compared to its average volume of 7,599. The company has a debt-to-equity ratio of 0.01, a current ratio of 25.25 and a quick ratio of 25.26. The company has a 50-day moving average price of $16.28 and a 200 day moving average price of $19.76. Celcuity has a 12-month low of $13.49 and a 12-month high of $29.96. The firm has a market cap of $157.07 million, a price-to-earnings ratio of -19.32 and a beta of 0.65.
CELC has been the topic of a number of analyst reports. Zacks Investment Research raised Celcuity from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a research note on Friday, October 11th. ValuEngine raised Celcuity from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd.
Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.
See Also: What is a price target?
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.